LAS VEGAS, Sept. 7, 2016 /PRNewswire-USNewswire/ -- VIVA Physicians, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, is excited to announce the late-breaking clinical trials to be presented at its annual conference, VIVA16. Sixteen trial results, featuring the latest in vascular technology, procedures and devices, will be released for the first time on Monday, Tuesday, and Wednesday, September 19, 20 and 21 at the Wynn, Las Vegas.
Trial results to be presented will have lasting impact on patient care and the development of new devices in the interventional treatment of peripheral arterial disease (PAD). Presentations of the late-breaking trial results will be made during the General Session and highlighted during press conferences. To view the detailed schedule and register to attend, visit the VIVA 16 Virtual Press Room.
Trial results to be presented:
Peripheral Arterial Disease
Twelve month results from the DANCE trial atherectomy cohort: a potentially lower-cost alternative with equivalent outcomes to drug-coated balloons.
Two year results of Paclitaxel coated balloons for long femoro-popliteal artery disease: Evidence from the SFA-Long Study.
ESPRIT I Trial: Three-year results of the ESPRIT Bioresorbable Vascular Scaffold in the treatment of patients with occlusive vascular disease of the superficial femoral or common or external iliac arteries.
MAJESTIC Two Year Results Plus Sub-group Analysis of the performance of the Eluvia stent for treating femoropopliteal artery lesions up to 110 mm in length.
Use of an expanded (ePTFE) balloon-expandable covered stent for obstructive lesions in the Iliac artery: nine year results from the prospective, multicenter BOLSTER Trial.
MOBILE Trial: MarrowStim™ PAD Kit for the treatment of critical limb ischemia in subjects with severe peripheral arterial disease.
Safety and performance of the Shockwave Lithoplasty® System in treating calcified peripheral vascular lesions: six month results from the two-phase DISRUPT PAD study.
Novel Nitinol stent for long lesions in the superficial femoral artery and proximal popliteal artery: 24-month results from the TIGRIS randomized trial.
PRISM Indigo Aspiration System as a tool for vacuum-assisted aspiration thrombectomy in the periphery.
New Procedures and Approaches
Arteriovenous fistula (AVF) post-creation interventions: a comparison between traditional surgical AVF creation and a new endovascular approach.
VIRTUS: Intravascular ultrasound for iliofemoral stenting IDE Trial.
Results from the IN.PACT SFA randomized trial comparing angioplasty to drug coated balloons.
Drug-coated balloon treatment for patients with intermittent claudication: insights from the IN.PACT Global full clinical cohort.
Endovascular repair in acute, complicated type B aortic dissection: three-year Results from the Valiant US-IDE Study.
Fast-Track endovascular aortic repair: final results from the prospective LIFE Registry.
Carotid Stent Fractures are not associated with restenosis, stroke, myocardial infarction or death: results from the ACT 1 multicenter randomized trial.
VIVA 16 Award Recipients
VIVA Physicians, in its ongoing mission to advance the field of vascular medicine will honor luminaries in the field with the following awards:
Mark Bates, MD, Professor of Medicine and Surgery at West Virginia University School of Medicine in Charleston, West Virginia, will receive the LIVE Award which honors A Leader In EndoVascular Education – recognizing vascular specialists who have dedicated their professional careers to educating students, post-graduate trainees, and peers in all aspects of vascular medicine and intervention.
Thomas Rooke, MD, former Head of the Section of Vascular Medicine and founder of the Mayo Clinic Wound Care Center, will be recognized with the ATLAS award, A Teacher, Leader, And, Scholar Award – The ATLAS Award has celebrated the career and impact of physicians who have distinguished themselves as scholars and leaders in their respective vascular fields.
Vascular Career Advancement Award
The 2016 Vascular Career Advancement Awards will be presented to Saher Sabri, MD and Antonio Micari, MD. VIVA and LINC have collaborated to develop the award to recognize young physicians who show promise as potential leaders in the vascular field and who have been practicing for 10 years or less. Dr. Saher Sabri is an interventional radiologist and currently Associate Professor of Radiology and Surgery at the University of Virginia. Dr. Micari is an interventional cardiologist, responsible for the CLI Program at Maria Cecilia Hospital in Ravenna, Italy. He is considered one of the leading international specialists in the PAD space and in limb salvage in patients with diabetic foot syndrome.
About VIVA Physicians
VIVA Physicians strive to be the premier educators in the field of vascular medicine and intervention. Our team of specialists in vascular medicine, interventional cardiology, interventional radiology and vascular surgery, is driven by the passion to advance the field of vascular medicine with a spirit of collegiality, by synergizing their collective talents to promote awareness and innovative therapeutic options for vascular disease worldwide. To learn more about VIVA Physicians, visit www.vivaphysicians.org.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/16-highly-anticipated-late-breaking-clinical-trials-to-be-presented-luminaries-to-be-honored-at-viva-16-300323268.html
SOURCE VIVA Physicians